Click Here for 5% Off Your First Aladdin Purchase!

SBP-7455 - 95%, high purity , CAS No.1884222-74-5, Inhibitor of unc-51 like autophagy activating kinase 1;Inhibitor of unc-51 like autophagy activating kinase 2

  • Moligand™
  • ≥95%
Item Number
S412916
Grouped product items
SKUSizeAvailabilityPrice Qty
S412916-5mg
5mg
In stock
$162.90
S412916-10mg
10mg
In stock
$271.90
S412916-25mg
25mg
In stock
$489.90
S412916-50mg
50mg
In stock
$706.90
S412916-100mg
100mg
In stock
$1,033.90
S412916-250mg
250mg
In stock
$2,326.90

Basic Description

Specifications & Purity95%
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of unc-51 like autophagy activating kinase 1;Inhibitor of unc-51 like autophagy activating kinase 2
Product Description

Information

SBP-7455 (compound 26) is a dual inhibitor of ULK1 and ULK2 that potently inhibits ULK1/2 enzymatic activity in vitro and in vivo. SBP-7455 inhibits starvation-induced autophagic flux in TNBC cells.

Associated Targets

ULK1 Tchem Serine/threonine-protein kinase ULK1 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ULK2 Tchem Serine/threonine-protein kinase ULK2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 4-N-cyclopropyl-2-N-(3,4-dimethoxyphenyl)-5-(trifluoromethyl)pyrimidine-2,4-diamine
INCHI InChI=1S/C16H17F3N4O2/c1-24-12-6-5-10(7-13(12)25-2)22-15-20-8-11(16(17,18)19)14(23-15)21-9-3-4-9/h5-9H,3-4H2,1-2H3,(H2,20,21,22,23)
InChi Key BQROJYIEHOOQBY-UHFFFAOYSA-N
Canonical SMILES COC1=C(C=C(C=C1)NC2=NC=C(C(=N2)NC3CC3)C(F)(F)F)OC
Isomeric SMILES COC1=C(C=C(C=C1)NC2=NC=C(C(=N2)NC3CC3)C(F)(F)F)OC
PubChem CID 132178569
Molecular Weight 354.33

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

6 results found

Lot NumberCertificate TypeDateItem
L2212141Certificate of AnalysisNov 04, 2022 S412916
L2212142Certificate of AnalysisNov 04, 2022 S412916
L2212143Certificate of AnalysisNov 04, 2022 S412916
L2212144Certificate of AnalysisNov 04, 2022 S412916
L2212145Certificate of AnalysisNov 04, 2022 S412916
L2212146Certificate of AnalysisNov 04, 2022 S412916

Related Documents

References

1. Ren H, Bakas NA, Vamos M, Chaikuad A, Limpert AS, Wimer CD, Brun SN, Lambert LJ, Tautz L, Celeridad M et al..  (2020)  Design, Synthesis, and Characterization of an Orally Active Dual-Specific ULK1/2 Autophagy Inhibitor that Synergizes with the PARP Inhibitor Olaparib for the Treatment of Triple-Negative Breast Cancer..  J Med Chem,  63  (23): (14609-14625).  [PMID:33200929]

Solution Calculators